We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.6B
AUM Growth
+$1.02B
Cap. Flow
+$301M
Cap. Flow %
2.05%
Top 10 Hldgs %
11.52%
Holding
3,073
New
178
Increased
750
Reduced
784
Closed
271

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Healthcare 15.18%
3 Financials 11.75%
4 Industrials 10.75%
5 Consumer Discretionary 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMID
1276
DELISTED
American Midstream Partners, LP
AMID
$83K ﹤0.01%
10,425
+6,725
+182% +$62.8K
INZ.CL
1277
DELISTED
Ing Groep N.v.
INZ.CL
$83K ﹤0.01%
3,230
ALLE icon
1278
Allegion
ALLE
$13.7B
$82K ﹤0.01%
1,267
CMC icon
1279
Commercial Metals
CMC
$7.8B
$82K ﹤0.01%
6,000
-6,000
-50% -$89.2K
KN icon
1280
Knowles
KN
$3.07B
$82K ﹤0.01%
6,276
-940
-13% -$16K
RF icon
1281
Regions Financial
RF
$26.7B
$82K ﹤0.01%
8,652
-48,060
-85% -$461K
SBRA icon
1282
Sabra Healthcare REIT
SBRA
$5.61B
$82K ﹤0.01%
4,076
+126
+3% +$2.65K
LPLA icon
1283
LPL Financial
LPLA
$27.4B
$81K ﹤0.01%
1,907
RSP icon
1284
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
$81K ﹤0.01%
1,057
-80
-7% -$6.21K
DASTY
1285
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
$81K ﹤0.01%
1,018
NWSA icon
1286
News Corp Class A
NWSA
$15.3B
$80K ﹤0.01%
6,122
-979,444
-99% -$13.8M
VRSK icon
1287
Verisk Analytics
VRSK
$27.8B
$80K ﹤0.01%
1,050
ARDX icon
1288
Ardelyx
ARDX
$1.25B
$79K ﹤0.01%
4,373
HUBG icon
1289
HUB Group
HUBG
$2.92B
$79K ﹤0.01%
4,840
PBE icon
1290
Invesco Biotechnology & Genome ETF
PBE
$288M
$79K ﹤0.01%
1,579
RAVN
1291
DELISTED
Raven Industries Inc
RAVN
$79K ﹤0.01%
5,081
+220
+5% +$3.82K
BCS.PRC
1292
DELISTED
BARCLAYS BK PLC SPONSORED ADS SER 4 PREF SHS (UK)
BCS.PRC
$79K ﹤0.01%
3,000
AOI
1293
DELISTED
Alliance One International
AOI
$79K ﹤0.01%
+6,920
New +$106K
ETW
1294
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.02B
$77K ﹤0.01%
6,995
EWJ icon
1295
iShares MSCI Japan ETF
EWJ
$21.3B
$77K ﹤0.01%
1,609
+4
+0.2% +$196
SLV icon
1296
iShares Silver Trust
SLV
$27.6B
$77K ﹤0.01%
5,875
-526
-8% -$7.41K
SRPT icon
1297
Sarepta Therapeutics
SRPT
$1.63B
$77K ﹤0.01%
2,000
TDG icon
1298
TransDigm Group
TDG
$73.2B
$77K ﹤0.01%
340
HDS
1299
DELISTED
HD Supply Holdings, Inc.
HDS
$77K ﹤0.01%
2,585
LM
1300
DELISTED
Legg Mason, Inc.
LM
$77K ﹤0.01%
1,989
-418,354
-100% -$17.9M

Similar funds

Glenmede Trust's Q4 2015 Portfolio in Review

As of Q4 2015, Glenmede Trust held 3,073 positions worth $14.6B, up 7.5% from $13.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust's Q4 2015 filing shows 178 new, 750 increased, 784 reduced and 271 closed positions. Its largest new stake was Alphabet (Google) Class A: 1,170,400 shares worth $45.5M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $51.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q4 2015 buy was Alphabet (Google) Class A: 1,170,400 shares worth $45.5M.
  • Glenmede Trust added most to VMware, Inc in Q4 2015, an estimated $75.2M increase.
  • Glenmede Trust's biggest Q4 2015 reduction was Microsoft, cutting an estimated $48.7M.
  • Glenmede Trust fully exited Vanguard FTSE Developed Markets ETF in Q4 2015, selling an estimated $51.1M.
  • Glenmede Trust's ten largest holdings make up 12% of its $14.6B portfolio in Q4 2015.
  • Glenmede Trust opened 178 new positions and closed 271 in Q4 2015.
  • Glenmede Trust's portfolio value rose 7.5% quarter-over-quarter to $14.6B.

Based on Glenmede Trust's 13F filing for Q4 2015, filed 11 Feb 2016.